Search

There is no established standard therapy for the treatment of mantle cell lymphoma (MCL). Instead, there is a range of treatment options and, to date, there has been a dearth of data to assist in clinical decision-making.

… Friday, December 8, 2017 There is no established standard therapy for the treatment of mantle cell lymphoma (MCL). Instead, there is a range of treatment options and, to date, there has been a dearth of data to assist in clinical decision-making. However, recent insights into the molecular and genomic

Candid conversations cover a wide range of topics for cancer patients and caregivers.

… Thursday, December 3, 2020 A cancer diagnosis is daunting, and while rapid fire advances in diagnosis, treatment, and research hold much promise, many patients find sorting through an explosion of online information challenging and confusing. Diane Reidy-Lagunes, MD , and colleagues offer guidance, support

The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.

… Tuesday, September 16, 2014 The Hartford HealthCare Cancer Institute (HHCCI) has been formally certified as the charter member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings

… Wednesday, September 28, 2022 When you ask Jose Casa what he does for a living he says, “I get paid to talk trash.” His answer — delivered with a comedian’s expert timing — clearly oversimplifies the important role Jose has played at Memorial Sloan Kettering Cancer Center (MSK) for almost three decades

In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.

… Tuesday, July 26, 2022 Many tumors can be eliminated with surgery , chemotherapy , radiation , and other treatments. But once cancer spreads, or metastasizes, to other parts of the body, it becomes much harder to stop. In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed

Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.

… Friday, September 10, 2021 VIDEO | 00:04 Abby Leaves Her Mark Abby's tattoo shows the latitude and longitude of Memorial Sloan Kettering Cancer Center and the quote "The comeback is always stronger than the setback." Video Details It was a bold request. A high school senior living outside Toledo named

A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.

… Thursday, September 19, 2024 Marylou Capes-Platt knew she was at an especially high risk for lung cancer . She had been a heavy smoker for 45 years, starting in her teens and continuing through a decades-long career in the music industry and as a writer and editor. She finally quit in 2007. But the threat

New MSK research finds the TCA cycle’s waste-management function may present an opportunity against cancer; shows how microplastics impair immune ‘housekeeping’ functions; reveals the way the protein TOX plays different roles in different immune cells; and identifies a new combination approach for treating advanced kidney cancer after immunotherapy.

… Monday, March 2, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) shows how microplastics impair immune ‘housekeeping’ functions; finds the TCA cycle’s waste-management function may present an opportunity against cancer; reveals the way the protein TOX plays different roles in different

Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.

… Wednesday, March 25, 2026 A new drug is showing promise in lung and pancreatic cancers — two of the most aggressive forms of cancer — by targeting one of the most common cancer-driving mutations. Setidegrasib, formerly known as ASP3082, tags and destroys the cancer-causing protein produced by the KRAS

Anthony DeMaio spent much of his younger life hiding from the spotlight. Today, he lives authentically in his personal and professional life. He also embraces the spotlight more figuratively — through a number of appearances on the small screen.

… Wednesday, June 22, 2022   Anthony DeMaio, senior physician relations liaison at MSK Anthony DeMaio, senior physician relations liaison at MSK Anthony DeMaio spent much of his younger life hiding from the spotlight. Today, he lives authentically in his personal and professional life. He also embraces